Cricothyroid onabotulinum toxin A injection to avert tracheostomy in bilateral vocal fold paralysis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 25123108.
- Also identified by DOI 10.1001/jamaoto.2014.1515.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
More than half of children with bilateral vocal fold paralysis require a tracheostomy for airway management. We report an innovative, minimally invasive approach consisting of onabotulinum toxin A injection into the cricothyroid muscles. Onabotulinum toxin A was injected under direct vision into the cricothyroid muscles of 6 pediatric patients with bilateral abductor vocal fold paralysis. None of the patients had fold fixation on laryngoscopy performed at the time of the injection. All patients had a documented increase in airway patency as visualized on flexible laryngoscopy within days after injection. This procedure successfully averted a tracheostomy in 5 patients and permitted decannulation of the sixth patient. Onabotulinum toxin A injection into the cricothyroid muscles leads to an increase in the glottic space, providing an adequate airway. Onabotulinum toxin A injection in the cricothyroid muscles could be offered as a safe, effective, noninvasive first-line option for patients with bilateral vocal fold paralysis.
Medical subject headings
- Airway Management
- Botulinum Toxins, Type A
- Laryngeal Muscles
- Neuromuscular Agents
- Vocal Cord Paralysis